Status:

COMPLETED

Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

Lead Sponsor:

Melbourne Health

Collaborating Sponsors:

Stanley Medical Research Institute

Conditions:

First Episode Psychosis

Eligibility:

All Genders

15-25 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to determine whether Vitamin B12,B6 and Folic Acid are effective with antipsychotic medication in the treatment of First Episode Psychosis.The B-complex Vitamins' homocyst...

Detailed Description

The core rationale of this study will be to prospectively investigate whether Vitamin B12, B6 and Folic Acid and the associated lowering of homocysteine levels will improve and /or protect cognitive f...

Eligibility Criteria

Inclusion

  • Male and females
  • Between 15 and 25 years of age
  • First Episode Psychosis
  • 3 months of treatment
  • Attending ORYGEN Youth Health, a geographical based catchment area service for young people aged between 15 and 25

Exclusion

  • Untreated B12 deficiency or untreated pernicious anaemia
  • Patients on multi-vitamins, single B6, or folic acid, unless willing to discontinue and take study supplement
  • Chronic haemolytic states such as thalassaemia major or sickle-cell anaemia
  • Hypersensitivity to folic acid
  • Organic disorders presenting with a psychotic syndrome (e.g. brain tumour, temporal lobe epilepsy, HIV encephalopathy)
  • Mental retardation (unable and/or unlikely to give appropriate information of symptomatology or side-effects (IQ approximately lower than 70)
  • History of clinically significant physical illness (e.g. terminal cancer, renal dialysis)
  • History of brain surgery
  • History of brain infarction
  • Pregnant or lactating women, or women of childbearing potential not using an acceptable method of contraception

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT00202280

Start Date

September 1 2004

End Date

June 1 2009

Last Update

November 20 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ORYGEN Youth Health

Melbourne, Victoria, Australia, 3052